OptiNose
OPTN
OPTN was delisted on the 20th of May, 2025.
0 hedge funds and large institutions have $0 invested in OptiNose in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 43 closing their positions.
70.94% less ownership
Funds ownership: 70.94% → 0% (-71%)
100% less funds holding
Funds holding: 43 → 0 (-43)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $66.2M → $0 (-$66.2M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 43
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.87M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$9.04M |
| 3 |
MP
MVM Partners
Boston,
Massachusetts
|
-$8.91M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$7.23M |
| 5 |
ACA
Acorn Capital Advisors
New York
|
-$3.88M |
OPTN Hedge Fund Activity: Q2 2025 in Review
0 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q2 2025, worth a combined $0 — down 100% from $66.2M a quarter earlier.
Sellers outnumbered buyers: 43 funds closed out of OPTN and 0 opened new positions — a net loss of 43 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Fidelity Investments, exiting entirely with an estimated $9.87M sold.
- 0 institutional investors held OptiNose (OPTN) as of Q2 2025, down from 43 in Q1 2025.
- Funds reported $0 of OptiNose stock for Q2 2025, down 100% quarter-over-quarter.
- 0 funds opened new OptiNose positions in Q2 2025 and 43 closed out, a net change of -43 holders.
- The largest OptiNose seller in Q2 2025 was Fidelity Investments, an estimated $9.87M sold.
Based on aggregated 13F filings for Q2 2025.